Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03221426
Brief Title: Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

First Submitted : July 17, 2017
First Submitted that Met QC Criteria : July 17, 2017
First Posted : July 18, 2017

Last Update Submitted that Met QC Criteria : May 20, 2021
Last Update Posted : May 24, 2021